Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Chronic Weight Management

Interventions

DRUG

HRS-7535

Trial Locations (1)

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06671821 - Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects | Biotech Hunter | Biotech Hunter